Home
Storia in 1 fonti
Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soon
Indian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federal Trade Commission for its takeover of Lannett Company. This regulatory approval removes the final hurdle. The acquisition is expected to close by the end of June.
Raccontata da
economictimes.indiatimes.com
Timeline cronologica
- ·
US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisition
The U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a condition for Aurobindo Pharma to finalize…
- ·
Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soon
Indian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federal Trade Commission for its takeover of…